Medical AI company VUNO announced Tuesday the publication of a large-scale, prospective study confirming the clinical ...
Daewoong Pharmaceutical has filed a phase 3 clinical trial application with Korea’s drug regulator to expand the label for ...
The time for innovative medical devices to enter clinical practice will be shortened to as early as 80 days.The Ministry of ...
JW Pharmaceutical said Monday that it shared clinical results and real-world prescribing experience for fostamatinib ...
As biological agents have become mainstream in dermatological treatment, Galderma, long known primarily for topical agents, ...
JLK, a medical AI company, said that the company will participate in the International Stroke Conference (ISC) 2026, held at ...
“Now I can run and play freely without taking drugs.”After eight years fighting hypereosinophilic syndrome (HES), a rare, ...
The pharmaceutical industry is directly challenging the government's proposed drug pricing reform, arguing the measures would ...
Otolaryngology departments are losing their foothold in tertiary general hospitals. The high clinical capabilities of private ...
1st Biotherapeutics said Monday it has successfully closed a Series D investment round worth 31.7 billion won ($22 million). This round closed above the initially planned investment size, bringing 1st ...
SAN FRANCISCO, Calif. – By Hong Sook / Korea Biomedical Review correspondent -- Targeted protein degraders (TPDs) are no ...
A ranking healthcare policymaker said that mandating ingredient-name prescribing could cause excessive disruption in the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results